Anti-TRNT1 / tRNA-nucleotidyltransferase 1 / CGI-47

Anti-TRNT1 / tRNA-nucleotidyltransferase 1 / CGI-47
Item number Size Datasheet Manual SDS Delivery time Quantity Price
NSJ-RQ8213 100 µg - -

3 - 10 business days*

790.00€
 
0.5mg/ml if reconstituted with 0.2ml sterile DI water. tRNA-nucleotidyltransferase 1, is an... more
Product information "Anti-TRNT1 / tRNA-nucleotidyltransferase 1 / CGI-47"
0.5mg/ml if reconstituted with 0.2ml sterile DI water. tRNA-nucleotidyltransferase 1, is an enzyme that in humans is encoded by the TRNT1 gene. The protein encoded by this gene is a CCA-adding enzyme which belongs to the tRNA nucleotidyltransferase/poly(A) polymerase family. This essential enzyme functions by catalyzing the addition of the conserved nucleotide triplet CCA to the 3' terminus of tRNA molecules. Mutations in this gene result in sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay. Alternative splicing results in multiple transcript variants. Protein function: Nucleotidyltransferase that catalyzes the addition and repair of the essential 3'-terminal CCA sequence in tRNAs, which is necessary for the attachment of amino acids to the 3' terminus of tRNA molecules, using CTP and ATP as substrates (PubMed:11504732, PubMed:31011209, PubMed:25193871, PubMed:25652405, PubMed:29454993, PubMed:34023389, PubMed:30959222, PubMed:25640237). tRNA 3'-terminal CCA addition is required both for tRNA processing and repair (PubMed:22076379, PubMed:25640237). Promotes tRNA repair and recycling downstream of the ribosome-associated quality control (RQC) pathway by mediating addition of the tRNA 3'-terminal CCA following cleavage by ANKZF1 and repair by ELAC1 (PubMed:31011209). Also involved in tRNA surveillance by mediating tandem CCA addition to generate a CCACCA at the 3' terminus of unstable tRNAs and tRNA-like transcripts (PubMed:22076379, PubMed:25640237). While stable tRNAs receive only 3'-terminal CCA, unstable tRNAs beginning with GG are marked with CCACCA and rapidly degraded (PubMed:22076379, PubMed:25640237). The structural flexibility of RNA controls the choice between CCA versus CCACCA addition: following the first CCA addition cycle, nucleotide-binding to the active site triggers a clockwise screw motion, producing torque on the RNA (PubMed:25640237). This ejects stable RNAs, whereas unstable RNAs are refolded while bound to the enzyme and subjected to a second CCA catalytic cycle (PubMed:25640237). [The UniProt Consortium]
Keywords: Anti-mt CCA-adding enzyme, Anti-mt tRNA CCA-diphosphorylase, Anti-mt tRNA adenylyltransferase, Anti-mt tRNA CCA-pyrophosphorylase, Anti-CCA tRNA nucleotidyltransferase 1, mitochondrial, Anti-Mitochondrial tRNA nucleotidyl transferase, CCA-adding, TRNT1 An
Supplier: NSJ Bioreagents
Supplier-Nr: RQ8213

Properties

Application: WB, IHC (paraffin), Direct ELISA
Antibody Type: Polyclonal
Conjugate: No
Host: Rabbit
Species reactivity: human
Immunogen: E. coli-derived recombinant human protein (amino acids M1-Q410)
Format: Translation

Handling & Safety

Storage: +4°C
Shipping: +4°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Anti-TRNT1 / tRNA-nucleotidyltransferase 1 / CGI-47"
Write a review
or to review a product.
Viewed